Applying Generative AI to the M&A Process
I recently came across a quote regarding AI in the professional world and the sentiment was basically this: Rather than being replaced by AI, a person is more likely to be replaced by a peer that is able to use AI to perform their job more efficiently. Generative Artificial Intelligence (GenAI) is rapidly being
adopted in Mergers and Acquisitions (M&A) workflows, with a majority
of organizations having moved past the experimentation phase and into execution.
A recent Big Four study, based on a survey of 1,000 senior corporate and
private equity (PE) M&A leaders, highlights the speed of adoption and the
challenges that remain.
Key Adoption Facts and Figures
- High
Integration Rate: 86% of responding organizations have
integrated GenAI into their M&A workflows. Of those, 65%
did so within the past year.
- Significant
Investment: 83% of GenAI adopters have invested $1 million
or more in the technology specifically for their M&A teams. This
includes 88% of private equity firms and 77% of corporate
organizations.
- Widespread
Use: Approximately 40% of organizations say they use GenAI in
more than half of their deals.
- Future Impact: Looking ahead, 83% of organizations expect GenAI to have a moderate or significant impact on M&A decision-making. Specifically, 35% anticipate a "significant impact" and 48% a "moderate impact" on decision-making within two years.
GenAI Across the M&A Life Cycle
GenAI sees the most traction in the pre-sign stages
of the M&A life cycle.
M&A Stage Percentage of Adopters
Actively Using GenAI
M&A Strategy & Market Assessment 40%
Due Diligence 35%
Target Identification & Screening 35%
Post-deal Integration & Value Realization 32%
Deal Execution 32%
Valuation 32%
- Top
Use Cases: 48% of GenAI adopters use it to generate initial
drafts of legal documents and regulatory findings. Also, 41% use it
during due diligence to analyze financial and operational data against
benchmarks.
Challenges and Adoption Strategies
The primary barriers to broader adoption center on data,
reliability, and compliance.
Top Barriers and Concerns
Area of Concern Percentage of
Respondents
Data security 67%
Data quality & availability 65%
GenAI model reliability & accuracy 64%
Ethical and bias concerns 62%
Regulatory & compliance 61%
Initial costs & budget constraints 56%
Lack of internal expertise & talent 54%
Deployment Strategies
Organizations are predominantly partnering externally or
developing internal platforms.
- For
32% of firms the most common approach is developing an
organization-wide, cross-department GenAI platform.
- 25%
of M&A outfits partnering with established technology providers
to customize tools is the second most common.
- 57%
of organizations are investing in workforce training and upskilling
to prepare teams for GenAI integration.
Overall, GenAI can basically be viewed as a "powerful
co-pilot" that enhances—rather than replaces— the unique value M&A
professionals bring.
Comments